Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heart rhythm mystery: study aims to crack why AF is stubborn in HCM patients

NCT ID NCT07454135

First seen Mar 16, 2026 · Last updated Jun 23, 2026 · Updated 11 times

Summary

This study will look at electrical signals and heart images from 40 people with both hypertrophic cardiomyopathy (HCM) and atrial fibrillation (AF). Researchers want to understand why AF happens more often and is harder to treat in HCM patients. The goal is to gather information that could lead to better treatments in the future.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Guy's and St Thomas' NHS Foundation Trust

    London, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this research could point toward better treatments for atrial fibrillation in people with hypertrophic cardiomyopathy.

What could go wrong

This is an early observational study with only 40 participants, so findings may not apply to everyone. It aims to gather knowledge, not test a new treatment directly.

Conditions

The condition(s) this trial relates to.

atrial fibrillation hypertrophic cardiomyopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.